The study morning will provide an introduction to immune checkpoint inhibitors in cancer management, exploring their associated side effects and offering practical strategies for managing them. This will be supported by relevant case studies. The session will be led by Dr Anna Olsson-Brown, who will cover the introduction and future of immune checkpoint inhibitors.

The event is designed for healthcare professionals, including oncology and non-oncology staff, medical teams, and nurses from emergency departments and oncology units. It promises to be a valuable opportunity for those involved in cancer care to share insights and learn from expert-led discussions.

The study morning will take place at Medway Maritime Hospital in Chatham, with registration and breakfast provided by BMS at 8:30am. The event is free of charge, and attendees will have opportunities for networking with fellow colleagues throughout the morning.

Details written from the information supplied by the event organiser.